Is a daily dose of 1.75 mg clonazepam considered a high dose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Is 1.75 mg Daily Clonazepam a High Dose?

Yes, 1.75 mg daily clonazepam is considered a moderately high dose that exceeds the optimal therapeutic range for most indications and approaches the upper limits recommended for certain conditions.

Context by Indication

For Panic Disorder

The FDA-approved dosing clearly establishes that the optimal dose for panic disorder is 1 mg/day, with doses of 2-4 mg/day showing less effectiveness and more adverse effects in controlled trials 1. Your dose of 1.75 mg exceeds the optimal therapeutic target by 75% and falls in the range where efficacy diminishes while side effects increase. Research confirms that daily doses of 1.0-2.0 mg offer the best balance of therapeutic benefit and tolerability 2.

For Seizure Disorders

For seizure management, the FDA label states the initial adult dose should not exceed 1.5 mg/day divided into three doses, with maintenance dosing individualized based on response 1. At 1.75 mg daily, you are above the recommended starting threshold but well below the maximum of 20 mg/day. However, this is still a moderate dose for seizure control.

For REM Sleep Behavior Disorder

The 2023 American Academy of Sleep Medicine guidelines note that clonazepam for secondary RBD in older adults with neurodegenerative disease typically starts at 0.25 mg, with lower doses preferred due to risks of morning sedation, falls, cognitive disturbances, and delirium 3. Your dose of 1.75 mg is 7 times higher than the typical starting dose and would be considered quite high in this population, particularly given that progressive cognitive decline and age-related impairments in drug metabolism often lead to intolerance.

Safety Considerations at This Dose

Critical concerns at 1.75 mg include:

  • Fall risk and ataxia: Particularly problematic in older adults, where even subtle postural instability combined with sedation can cause nighttime falls 3
  • Cognitive impairment: Including delirium, amnesia, and memory problems 1
  • Morning sedation and daytime impairment 3, 1
  • Increased dependence risk: Higher doses carry greater risk of physical dependence and more severe withdrawal reactions upon discontinuation 1
  • Respiratory depression: Especially when combined with other CNS depressants 1

The American Geriatrics Society lists clonazepam on the Beers Criteria as potentially inappropriate in older adults 3, making doses above 1 mg particularly concerning in this population.

Dose-Response Evidence

Research demonstrates that doses above 1 mg for panic disorder do not provide additional benefit but do increase adverse effects 2. The study found completion rates and tolerability were better at 1-2 mg daily compared to 3-4 mg daily, with somnolence and ataxia reported more frequently at higher doses.

Clinical Recommendation

Your 1.75 mg dose should be considered high for panic disorder and very high for RBD, warranting careful reassessment of necessity and consideration of dose reduction. If you're taking this for panic disorder, you're 75% above the optimal dose. If for RBD (especially with neurodegenerative disease), you're at a dose that significantly increases risk of falls, cognitive decline, and other serious adverse effects without clear additional benefit.

Consider discussing with your prescriber whether the dose can be reduced to 1 mg or lower, particularly if you're experiencing side effects or are over 65 years old.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.